{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T15:18:24Z","timestamp":1776439104304,"version":"3.51.2"},"reference-count":20,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2004,2,15]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p> African Americans have the highest cancer mortality rates and poorest survival and are more often uninsured and underinsured compared with other ethnic groups. Minority participation in clinical trials has traditionally been low, with reports ranging from 3% to 20%. The present study systematically assesses 235 consecutively diagnosed African American cancer patients regarding recruitment onto cancer treatment clinical trials at Howard University Cancer Center between January 1, 2001, and December 31, 2002. Our intent is to determine the rate-limiting factors associated with enrolling African Americans onto clinical trials at a historically black medical institution. <\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and Methods<\/jats:title><jats:p> Two hundred thirty-five consecutively diagnosed African American cancer patients were assessed for participation in clinical trials at Howard University Hospital and Cancer Center. The study population comprised 165 women and 70 men. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p> The overall eligibility rate was 8.5% (20 of 235 patients); however, among those eligible, the enrollment rate (ie, enrollment among the eligible population) was 60.0% (12 of 20 patients). Comorbidities rendered 17.1% of the patient population ineligible for the trials. Advanced disease stage, associated with poor performance status, premature death, and short life expectancy, made an additional 10% of the patient population ineligible. Respiratory failure, HIV positivity, and anemia accounted for 37.8% of the comorbidities in this population. Cardiovascular diseases and renal insufficiency represented 16.2% of the comorbidities. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p> It was evident that study design exclusion and inclusion criteria rendered the majority of the study population ineligible. Among African Americans, comorbidity is a major issue that warrants considerable attention. <\/jats:p><\/jats:sec>","DOI":"10.1200\/jco.2004.03.160","type":"journal-article","created":{"date-parts":[[2004,2,14]],"date-time":"2004-02-14T02:18:29Z","timestamp":1076725109000},"page":"730-734","source":"Crossref","is-referenced-by-count":170,"title":["Enrollment of African Americans Onto Clinical Treatment Trials: Study Design Barriers"],"prefix":"10.1200","volume":"22","author":[{"given":"Lucile L.","family":"Adams-Campbell","sequence":"first","affiliation":[{"name":"From the Cancer Center, Division of Cancer Prevention, Control, and Population Sciences; the Department of Surgery; and the Department of Medicine, Howard University College of Medicine, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiledum","family":"Ahaghotu","sequence":"additional","affiliation":[{"name":"From the Cancer Center, Division of Cancer Prevention, Control, and Population Sciences; the Department of Surgery; and the Department of Medicine, Howard University College of Medicine, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvin","family":"Gaskins","sequence":"additional","affiliation":[{"name":"From the Cancer Center, Division of Cancer Prevention, Control, and Population Sciences; the Department of Surgery; and the Department of Medicine, Howard University College of Medicine, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fitzroy W.","family":"Dawkins","sequence":"additional","affiliation":[{"name":"From the Cancer Center, Division of Cancer Prevention, Control, and Population Sciences; the Department of Surgery; and the Department of Medicine, Howard University College of Medicine, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duane","family":"Smoot","sequence":"additional","affiliation":[{"name":"From the Cancer Center, Division of Cancer Prevention, Control, and Population Sciences; the Department of Surgery; and the Department of Medicine, Howard University College of Medicine, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavius D.","family":"Polk","sequence":"additional","affiliation":[{"name":"From the Cancer Center, Division of Cancer Prevention, Control, and Population Sciences; the Department of Surgery; and the Department of Medicine, Howard University College of Medicine, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Gooding","sequence":"additional","affiliation":[{"name":"From the Cancer Center, Division of Cancer Prevention, Control, and Population Sciences; the Department of Surgery; and the Department of Medicine, Howard University College of Medicine, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"DeWitty","sequence":"additional","affiliation":[{"name":"From the Cancer Center, Division of Cancer Prevention, Control, and Population Sciences; the Department of Surgery; and the Department of Medicine, Howard University College of Medicine, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"R1","unstructured":"Haynes MA, Smedley BC The unequal burden of Cancer: Committee on Cancer Research Among Minorities and the Medically Underserved . Washington, DC, Institute of Medicine, National Academy Press, 1999"},{"key":"R2","unstructured":"Cancer Facts and Figures for African-Americans 2000\u20132001 . Atlanta, GA, American Cancer Society, pp 2,2000\u20137"},{"key":"R3","unstructured":"Ries LAG, Eisner MP, Kosary CL, et al (eds): SEER Cancer Statistics Review, 1979\u20131997 . Bethesda, MD, National Cancer Institute, 2000"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.2188\/jea.10.22"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.23.1747"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19941101)74:9+<2687::AID-CNCR2820741817>3.0.CO;2-B"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Millon-Underwood S, Sander E, Davis M: Determinants of participation in state-of-the-art cancer prevention, early detection\/screening, and treatment trials among African-Americans. Cancer Nurs 16:25,1993\u201333,","DOI":"10.1097\/00002820-199302000-00002"},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19931101)72:9+<2834::AID-CNCR2820721512>3.0.CO;2-J"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(87)90004-3"},{"key":"R10","unstructured":"Mouton CP, Harris S, Rovi S, et al: Barriers to black women's participation in cancer clinical trials. J Natl Med Assoc 89:721,1997\u2013727,"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/S1047-2797(00)00191-5"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.3.1029"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-199902000-00005"},{"key":"R14","unstructured":"Green BL, Partridge EE, Fouad MN, et al: African-American attitudes regarding cancer clinical trials and research studies: Results from focus group methodology. Ethn Dis 10:76,2000\u201386,"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(85)90121-7"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1016\/0277-9536(92)90169-Q"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198405243102106"},{"key":"R18","unstructured":"Elks ML: The right to participate in research studies. J Lab Clin Med 122:130,1993\u2013136,"},{"key":"R19","unstructured":"Haynes MA, Bernard LJ: Drew\/Meharry\/Morehoue Consortium Cancer Center: An approach to targeted research in minority institutions. J Natl Med Assoc 84:505,1992\u2013511,"},{"key":"R20","unstructured":"Ross RK, Bernstein L, Judd H, et al: Serum testosterone levels in young black and white men. J Natl Cancer Inst 76:45,1986\u201348,"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2004.03.160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T20:24:57Z","timestamp":1653510297000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2004.03.160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2,15]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,2,15]]}},"alternative-id":["10.1200\/JCO.2004.03.160"],"URL":"https:\/\/doi.org\/10.1200\/jco.2004.03.160","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2,15]]}}}